Achieving blood pressure targets and antihypertensive effects through metabolic surgery in type 2 diabetes patients with hypertension.

Diabetes/metabolism Research and Reviews
Fang SunZhiming Zhu

Abstract

The effect of metabolic surgery compared with that of conventional therapy on target blood pressure (BP)and defined daily dose (DDD) of antihypertensive drugs in type 2 diabetes (T2DM) patients with hypertension remains unclear. This study aimed to investigate the differences in target BP and DDD between metabolic surgery and conventional treatment in T2DM patients with hypertension. This was a prospective study of 535 diabetes patients who underwent metabolic surgery (n = 112) and medical treatment (n = 423). Changes in the target BP from baseline to every follow-up were analysed. Metabolic surgery decreased both office systolic and diastolic BP (DBP) and also significantly reduced ambulatory systolic BP (SBP; 132 ± 2 vs. 119 ± 1 mmHg, p < 0.0001), but not DBP (78 ± 1 vs. 76 ± 1 mmHg, p = 0.177). Patients maintained their SBP at <120 mmHg after 2 years (50% vs. 1.9%, p < 0.0001). Moreover, the rate of achieving the target SBP of 130 and 140 mmHg was also significantly higher in the surgery group, and this started from the initial 6 months after commencing treatment to the end of follow-up. The dosage (DDD: 1.44 ± 0.65 vs. 0.32 ± 0.05, p < 0.001) of antihypertensive medication was significantly decreased after metabolic surgery...Continue Reading

References

May 6, 2006·FEBS Letters·Yuji Matsuzawa
Nov 14, 2007·Metabolism: Clinical and Experimental·Zhigang ZhaoZhiming Zhu
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Oct 23, 2009·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Shashank S ShahDavid E Cummings
Mar 28, 2012·The New England Journal of Medicine·Philip R SchauerDeepak L Bhatt
Aug 24, 2012·The New England Journal of Medicine·Lena M S CarlssonLars Sjöström
Aug 21, 2013·Hypertension·Anna NiemirskaElżbieta Jurkiewicz
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Feb 16, 2017·The New England Journal of Medicine·Philip R SchauerUNKNOWN STAMPEDE Investigators
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Oct 28, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masami Tanaka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.